RA Medication summary guide and RA Choice for Rheumatoid Arthritis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
San Francisco VA Medical Center, San Francisco, CA, San Francisco, CA
Rheumatoid Arthritis+2 More
RA Medication summary guide and RA Choice - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform effective ways to implement this practice in the care of Veterans with RA. The purpose of this project is to evaluate the effectiveness of a multi-component shared decision making intervention on RA disease activity, adherence to RA medications and patient knowledge of RA. The proposed research will contribute to fundamental knowledge about how to effectively foster shared decision making across varied VA rheumatology clinical settings to improve patient disease outcomes and experience; and support clinicians to engage patients in meaningful ways with the ultimate goal to improve health, reduce disability, and eliminate disparities.

Eligible Conditions

  • Rheumatoid Arthritis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: through study completion (up to 4 years), on average 3 times per year

Month 12
Change in adherence
Change in rheumatoid arthritis knowledge
Year 4
Change in OPTION-5 (objective measure of shared decision making)
Year 4
CollaboRATE questionnaire
Disease activity
SURE questionnaire

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

2196 Total Participants · 2 Treatment Groups

Primary Treatment: RA Medication summary guide and RA Choice · No Placebo Group · N/A

InterventionExperimental Group · 3 Interventions: Clinician communication training, Patient activation, RA Medication summary guide and RA Choice · Intervention Types: Behavioral, Behavioral, Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion (up to 4 years), on average 3 times per year
Closest Location: San Francisco VA Medical Center, San Francisco, CA · San Francisco, CA
Photo of San Francisco 1Photo of San Francisco 2Photo of San Francisco 3
2007First Recorded Clinical Trial
1 TrialsResearching Rheumatoid Arthritis
33 CompletedClinical Trials

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,459 Previous Clinical Trials
2,746,717 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
22 Patients Enrolled for Rheumatoid Arthritis
Jennifer Barton, MDPrincipal InvestigatorVA Portland Health Care System, Portland, OR

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have rheumatoid arthritis.
You must be between the ages of 18 and 65 years old.
You have received rheumatology outpatient care at participating clinics and seen at least once in the past 12 months.
You are a leader in your institution for at least 12 months prior to enrollment.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.